M. Mordak-Domagała

发表

Role of Donor Activating KIR-HLA Ligand-Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients.

W. Jędrzejczak, A. Tomaszewska, J. Wachowiak, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intra-bone donor lymphocyte infusion at relapse: clinical outcome is associated with presence of CD8+ cells in the marrow

E. Jaskuła, M. Mordak-Domagała, J. Lange, 2019, Bone Marrow Transplantation.

Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group study

K. Sułek, T. Robak, E. Patkowska, 2015, Leukemia & lymphoma.

Beneficial effect of the CXCL12-3'A variant for patients undergoing hematopoietic stem cell transplantation from unrelated donors.

W. Jędrzejczak, A. Tomaszewska, D. Duda, 2015, Cytokine.

The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow

A. Simiczyjew, D. Nowak, G. Dworacki, 2018, PloS one.

Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial

W. Wiktor-Jedrzejczak, K. Sułek, T. Robak, 2017, American journal of hematology.

Donor lymphocyte infusions to leukemic bone lesions are therapeutically effective in a Ph+ ALL patient with post-HSCT relapse

A. Klimczak, E. Jaskuła, M. Mordak-Domagała, 2014, Journal of immunotoxicology.

Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients

W. Jędrzejczak, A. Tomaszewska, J. Wachowiak, 2014, American journal of hematology.

NOD2/CARD15 single nucleotide polymorphism 13 (3020insC) is associated with risk of sepsis and single nucleotide polymorphism 8 (2104C>T) with herpes viruses reactivation in patients after allogeneic hematopoietic stem cell transplantation.

W. Jędrzejczak, J. Nowak, K. Warzocha, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CD14 + HLADR- blood values in patients after alloHSCT are highly predictive of survival and infectious complications.

E. Jaskuła, M. Mordak-Domagała, J. Lange, 2021, Transplant immunology.

CCR5 gene polymorphism affects the risk of GvHD after haematopoietic stem cell transplantation from an unrelated donor

W. Jędrzejczak, D. Duda, A. Kucharska, 2015, British journal of haematology.

Anti-CMV-IgG Positivity of Donors Is Beneficial for alloHSCT Recipients with Respect to the Better Short-Term Immunological Recovery and High Level of CD4+CD25high Lymphocytes

S. Mizia, E. Jaskuła, M. Mordak-Domagała, 2015, Viruses.

Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation‐ineligible relapsed and refractory diffuse large B‐cell lymphoma

J. Zaucha, J. Walewski, A. Pluta, 2022, British journal of haematology.

Efficacy of daratumumab monotherapy in real-world heavily pretreated patients with relapsed or refractory multiple myeloma.

J. Zaucha, K. Giannopoulos, A. Pasternak, 2019, Advances in medical sciences.